WealthTrust-Arizona’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$80K Buy
866
+800
+1,212% +$70.4K 0.05% 108
2018
Q3
$6K Buy
66
+11
+20% +$1.04K ﹤0.01% 472
2018
Q2
$5K Hold
55
﹤0.01% 498
2018
Q1
$5K Buy
55
+1
+2% +$110 ﹤0.01% 483
2017
Q4
$5K Hold
54
﹤0.01% 482
2017
Q3
$5K Buy
54
+1
+2% +$76 ﹤0.01% 486
2017
Q2
$4K Sell
53
-139
-72% -$9.35K ﹤0.01% 498
2017
Q1
$13K Buy
192
+1
+0.5% +$63 0.01% 329
2016
Q4
$12K Hold
191
0.01% 337
2016
Q3
$12K Buy
191
+1
+0.5% +$65 0.01% 333
2016
Q2
$12K Hold
190
0.01% 322
2016
Q1
$11K Buy
190
+1
+0.5% +$56 0.01% 329
2015
Q4
$11K Sell
189
-110
-37% -$6.34K 0.01% 359
2015
Q3
$16K Buy
299
+10
+3% +$651 0.01% 297
2015
Q2
$19K Buy
289
+169
+141% +$11K 0.01% 292
2015
Q1
$7K Sell
120
-150
-56% -$9.06K ﹤0.01% 459
2014
Q4
$18K Sell
270
-152
-36% -$9.58K 0.02% 300
2014
Q3
$24K Buy
422
+73
+21% +$4.05K 0.03% 246
2014
Q2
$20K Buy
349
+2
+0.6% +$105 0.02% 281
2014
Q1
$18K Buy
347
+3
+0.9% +$152 0.02% 311
2013
Q4
$18K Buy
344
+3
+0.9% +$147 0.02% 287
2013
Q3
$15K Buy
341
+3
+0.9% +$133 0.02% 285
2013
Q2
$14K Buy
+338
New +$14.8K 0.02% 274

Other funds holding ABBV

WealthTrust-Arizona's ABBV Position: Q4 2018 in Review

WealthTrust-Arizona increased its AbbVie (ABBV) stake by 1,212% in Q4 2018, buying an estimated $70.4K and bringing the position to 866 shares worth $80K. The position accounts for 0.05% of the portfolio, ranked #108.

WealthTrust-Arizona first reported a position in ABBV in Q2 2013 and has held it in 23 quarters since. 2,062 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • WealthTrust-Arizona held 866 shares of AbbVie worth $80K as of Q4 2018.
  • WealthTrust-Arizona bought 800 AbbVie shares in Q4 2018, an estimated $70.4K.
  • AbbVie made up 0.05% of WealthTrust-Arizona's portfolio in Q4 2018, its #108 holding.
  • WealthTrust-Arizona first reported a position in AbbVie in Q2 2013 and has held it in 23 quarters since.
  • 2,062 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.